OTCMOTSKY
Market cap29bUSD
Dec 23, Last price
27.35USD
1D
0.96%
1Q
-2.88%
Jan 2017
24.77%
IPO
-8.13%
Name
Otsuka Holdings Co Ltd
Chart & Performance
Profile
Otsuka Holdings Co., Ltd. engages in pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. The company develops pharmaceutical products in the fields of oncology, cardiovascular system, renal system, digestive system, ophthalmology, diagnostics, and intravenous solutions, as well as medical devices businesses. It also provides EQUELLE, a product for women's health and beauty; BODYMAINTÉ Jelly, a conditioning food product; BODYMAINTÉ Drink, a drinkable-liquid; POCARI SWEAT, a drink; Calorie Mate, a nutritional food; OS-1, an oral rehydration solution; HINEX-R, a concentrated liquid diet; and Oronine H Ointment, a household antiseptic medicine. In addition, the company offers soft drinks, food products, and wines; chemicals; clinical testing and medical equipment; cosmetics; warehousing and transport services; analysis and measurement equipment; pharmaceutical intermediates; vehicle headlight testers; synthetic resin molded products; paper products; artificial turf; ceramic boards, ceramic walls, reliefs, terracotta, OT ceramics, and ceramic portraits and sign boards; functional films; stable isotopes; software and services to enhance management of mental healthcare systems; potassium titanate; polyolefin foams; spring and mineral water; industrial chemicals; hydrazine; insecticide and toiletry products; and adhesive tapes. Further, it operates a hotel. Otsuka Holdings Co., Ltd. was founded in 1921 and is based in Tokyo, Japan.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | 2014‑12 | |
Income | ||||||||||
Revenues | 2,018,568,000 16.14% | 1,737,998,000 16.00% | 1,498,276,000 5.30% | |||||||
Cost of revenue | 1,726,378,000 | 1,568,860,000 | 1,349,655,000 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 292,190,000 | 169,138,000 | 148,621,000 | |||||||
NOPBT Margin | 14.48% | 9.73% | 9.92% | |||||||
Operating Taxes | 17,155,000 | 35,534,000 | 34,429,000 | |||||||
Tax Rate | 5.87% | 21.01% | 23.17% | |||||||
NOPAT | 275,035,000 | 133,604,000 | 114,192,000 | |||||||
Net income | 121,616,000 -9.18% | 133,906,000 6.73% | 125,463,000 -15.31% | |||||||
Dividends | (55,653,000) | (55,561,000) | (55,984,000) | |||||||
Dividend yield | 1.94% | 2.38% | 2.48% | |||||||
Proceeds from repurchase of equity | (1,000) | (1,000) | ||||||||
BB yield | 0.00% | 0.00% | ||||||||
Debt | ||||||||||
Debt current | 88,272,000 | 44,157,000 | 49,973,000 | |||||||
Long-term debt | 201,477,000 | 223,950,000 | 239,302,000 | |||||||
Deferred revenue | 44,869,000 | 50,736,000 | 57,771,000 | |||||||
Other long-term liabilities | 59,740,000 | 70,826,000 | 60,005,000 | |||||||
Net debt | (700,041,000) | (622,691,000) | (523,155,000) | |||||||
Cash flow | ||||||||||
Cash from operating activities | 283,232,000 | 211,848,000 | 228,864,000 | |||||||
CAPEX | (114,673,000) | (107,787,000) | (113,152,000) | |||||||
Cash from investing activities | (190,538,000) | (81,575,000) | (95,288,000) | |||||||
Cash from financing activities | (60,168,000) | (95,474,000) | (95,844,000) | |||||||
FCF | 150,796,000 | 102,834,000 | 118,484,000 | |||||||
Balance | ||||||||||
Cash | 513,341,000 | 489,115,000 | 430,758,000 | |||||||
Long term investments | 476,449,000 | 401,683,000 | 381,672,000 | |||||||
Excess cash | 888,861,600 | 803,898,100 | 737,516,200 | |||||||
Stockholders' equity | 1,974,755,000 | 1,800,822,000 | 1,598,082,000 | |||||||
Invested Capital | 1,866,251,400 | 1,746,031,900 | 1,627,411,800 | |||||||
ROIC | 15.23% | 7.92% | 7.22% | |||||||
ROCE | 10.50% | 6.56% | 6.21% | |||||||
EV | ||||||||||
Common stock shares outstanding | 542,668 | 542,556 | 542,377 | |||||||
Price | 5,289.00 22.86% | 4,305.00 3.26% | 4,169.00 -5.64% | |||||||
Market cap | 2,870,171,052 22.88% | 2,335,703,580 3.30% | 2,261,169,713 -5.63% | |||||||
EV | 2,212,764,052 | 1,750,152,580 | 1,786,256,713 | |||||||
EBITDA | 389,967,000 | 262,899,000 | 233,476,000 | |||||||
EV/EBITDA | 5.67 | 6.66 | 7.65 | |||||||
Interest | 6,523,000 | 6,063,000 | 4,840,000 | |||||||
Interest/NOPBT | 2.23% | 3.58% | 3.26% |